Matinas BioPharma Holdings MTNB
NYSE MTNB
$2.64 +0.22 (+9.09%)
As of: Oct 2, 2026 · 3:05 PM EDT

Matinas BioPharma Holdings (MTNB) Short-term Investments (2019 - 2024)

Updated

Matinas BioPharma Holdings (MTNB) reported Short-term Investments of $500,000 for Q3 2024, down 95.8% from $11.81 million a year earlier and down 95.0% from the prior quarter.

Analysis

Matinas BioPharma Holdings (MTNB) Short-term Investments (2019 - 2024) Analysis & Trends

At the end of FY2023, Matinas BioPharma Holdings posted Short-term Investments of $8.97 million, down 59.1% from FY2022.

  • Short-term Investments has declined for three consecutive years, though with a four-year compound annual growth rate of 12.5% (FY2019 to FY2023).
  • By year, Short-term Investments came in at $21.93 million in FY2022 (-23.3%), $28.59 million in FY2021 (-38.2%), $46.25 million in FY2020 (+725.1%) and $5.6 million in FY2019.
  • The Q3 2024 figure ranks as the lowest quarterly Short-term Investments in data going back to Q4 2019.
  • Year over year, Short-term Investments has now declined in each of the last 15 quarters, with an average decline of 48.1% over the last eight quarters.
  • The high point for year-over-year Short-term Investments in five years was Q4 2020 (growth of 725.1%); the low point was Q3 2024 (a decline of 95.8%).
  • Per Business Quant data, the three quarters before Q3 2024 came in at $10.1 million (Q2 2024), $7.04 million (Q1 2024) and $8.97 million (Q4 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Matinas BioPharma Holdings 16.34 Mn 3.74 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 500,000.00
Jun 30, 2024 10.10 Mn
Mar 31, 2024 7.04 Mn
Dec 31, 2023 8.97 Mn
Sep 30, 2023 11.81 Mn
Jun 30, 2023 12.77 Mn
Mar 31, 2023 19.12 Mn
Dec 31, 2022 21.93 Mn
Sep 30, 2022 21.88 Mn
Jun 30, 2022 28.10 Mn
Mar 31, 2022 24.54 Mn
Dec 31, 2021 28.59 Mn
Sep 30, 2021 28.91 Mn
Jun 30, 2021 29.50 Mn
Mar 31, 2021 37.30 Mn
Dec 31, 2020 46.25 Mn
Sep 30, 2020 55.72 Mn
Jun 30, 2020 53.10 Mn
Mar 31, 2020 61.09 Mn
Dec 31, 2019 5.60 Mn
API Access

Matinas BioPharma Holdings Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=MTNB&period=max&api_key=YOUR_API_KEY